Molecule Information
General Information of the Molecule (ID: Mol00299)
Name |
Solute carrier family 31 member 1 (SLC31A1)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
Copper transporter 1; hCTR1; Solute carrier family 31 member 1; COPT1; CTR1
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
SLC31A1
|
||||
Gene ID | |||||
Location |
chr9:113221544-113264492[+]
|
||||
Sequence |
MDHSHHMGMSYMDSNSTMQPSHHHPTTSASHSHGGGDSSMMMMPMTFYFGFKNVELLFSG
LVINTAGEMAGAFVAVFLLAMFYEGLKIARESLLRKSQVSIRYNSMPVPGPNGTILMETH KTVGQQMLSFPHLLQTVLHIIQVVISYFLMLIFMTYNGYLCIAVAAGAGTGYFLFSWKKA VVVDITEHCH Click to Show/Hide
|
||||
Function |
High-affinity, saturable copper transporter involved in dietary copper uptake.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Ensembl ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
||||
Disease Class: Lung cancer | [1] | |||
Sensitive Disease | Lung cancer [ICD-11: 2C25.5] | |||
Sensitive Drug | Cisplatin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell proliferation | Inhibition | hsa05200 | |
Ubiquitin-proteasome signaling pathway | Regulation | hsa05017 | ||
In Vitro Model | H460 cells | Lung | Homo sapiens (Human) | CVCL_0459 |
H1299 cells | Lung | Homo sapiens (Human) | CVCL_0060 | |
A459 cells | Lung | Homo sapiens (Human) | CVCL_0023 | |
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
MTT assay | |||
Mechanism Description | NEAT1 may act as a competing endogenous LncRNA to upregulate EGCG-induced CTR1 by sponging hsa-mir-98-5p to upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. |
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
Differential expression of molecule in resistant diseases | ||
The Studied Tissue | Lung | |
The Specified Disease | Lung cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 8.17E-14; Fold-change: -2.70E-01; Z-score: -4.89E-01 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.62E-02; Fold-change: 9.46E-02; Z-score: 2.43E-01 | |
Molecule expression in the normal tissue adjacent to the diseased tissue of patients
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances |
![]() |
Click to View the Clearer Original Diagram |
Tissue-specific Molecule Abundances in Healthy Individuals
![]() |
||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.